1. AstraZeneca Investors Press Exec-Comp Chair to Tie Pay to Pfizer Bid

    AstraZeneca Investors Press Exec-Comp Chair to Tie Pay to Pfizer Bid

    To follow through on calls to link AstraZeneca executive pay to the value of Pfizer's ($PFE) rejected buyout offer. Last month, AstraZeneca rebuffed the U.S. drug giant's £55 per share bid, saying shareholders would be better served if the company pursued its ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned